Skip to main content
OpenTrials

Clinical trial condition

Fragile X Syndrome

Explore clinical trials studying Fragile X Syndrome. Study availability and eligibility vary by location and protocol.

77 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Fragile X Syndrome trial results

Completed

Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)

NCT03614663

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research and Resource Center Phoenix, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UC Davis Health System, MIND Institute Sacramento, California, United States
  • Children's Hospital of Colorado Denver, Colorado, United States
View all 21 locations
View Trial Details
Completed

Study of Acamprosate in Fragile x Syndrome

NCT01911455

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome

NCT01253629

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Decatur, Georgia, United States
  • Novartis Investigative Site Chicago, Illinois, United States
View all 31 locations
View Trial Details
Completed

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

NCT01482143

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Nashville, Tennessee, United States
  • Novartis Investigative Site Sant Cugat del Vallès, Catalonia, Spain
View Trial Details

Related conditions